COVID-19 and its infections are spreading like a forest fire and there is a huge sigh and worry across the globe. In these hard times, Cipla brings some good news.
The drug to treat COVID-19 will be out in the market in a few days. It is called Remesivir and there are clinical trials proven that this drug speeds up the recovery of patients.
Each vial of this drug will be sold for 4,000INR and Dr. Reddy’s Laboratories Ltd.; Hetero Labs Ltd.; Syngene, a Biocon company; and Zydus Cadila Healthcare Ltd. along with Cipla are allowed to manufacture this drug.